Sponsored Satellite Symposia
Sponsored Satellite Symposia
Thursday, 4 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
20.00 - 21.00
INDUSTRY-SPONSORED WELCOME COCKTAIL
Friday, 5 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
Auditorium A
ABIOGEN BREAKFAST SYMPOSIUM - Vitamin D for Muscle-Skeletal Health
Chairperson: ‣ Maria Luisa Brandi
‣ Vitamin D for Bone Health René Rizzoli
‣ Vitamin D for Muscle Health Bess Dawson‑Hughes
12.15 - 13.45
Auditorium A
MYLAN SATELLITE LUNCH SYMPOSIUM - Crystalline glucosamine sulfate: exploring the efficacy for potential new indications
Chairpersons: ‣ Alberto Migliore, ‣ Jean‑Yves Reginster
‣ ESCEO recommendations for clinical trials for hand OA Jean‑Yves Reginster
‣ Hand osteoarthritis: specificities and similarities with knee OA - a short overview Emmanuel Maheu
‣ A new opportunity to treat hand Osteoarthritis: the role of crystalline glucosamine sulfate Sara Tenti
‣ The challenge of early symptomatic knee osteoarthritis (ESKOA) Alberto Migliore
‣ Serum kinetics od cartilage biological markers in response to immobilization and physical exercise, and the potential role of CGS in this context Anna‑Maria Liphardt
‣ Opening of discussion Jean‑Yves Reginster
‣ Conclusion
12.15 - 13.45
Auditorium B
UCB SATELLITE LUNCH SYMPOSIUM - Treating to target – a reality on the horizon?
Chairperson: ‣ Kassim Javaid
‣ Why do we need to change our approach for patients with fragility fractures? Kassim Javaid
‣ What can we learn from other therapy areas? Clifford J. Bailey, Serge Ferrari
‣ What could we be targeting for patients with fragility fractures? Serge Ferrari
‣ How do we apply the evidence when all patients are different?
Including audience exercise Bente Langdahl facilitated by Kassim Javaid
Including audience exercise Bente Langdahl facilitated by Kassim Javaid
‣ Where have we landed? Kassim Javaid, Serge Ferrari, Bente Langdahl
17.00 - 18.30
Auditorium A
KYOWA KIRIN SATELLITE SYMPOSIUM - THE MANY FACES OF RARE BONE DISEASE
Chairpersons: ‣ Cyrus Cooper, ‣ Christian Roux
‣ Welcome and introductions Cyrus Cooper, Christian Roux
‣ Phosphate wasting disorders in adults: a clinical overview Maria Luisa Brandi
‣ Case report 1: Unexplained fractures in a previously healthy young adult Salvatore Minisola
‣ Case report 2: How to find the needle in the haystack? Lars Rejnmark
‣ Case report 3: A case of mistaken identity: spondyloarthritis or not? Karine Briot
‣ Q&A Christian Roux
‣ Summary and close Cyrus Cooper
17.00 - 18.30
Auditorium B
IBSA Satellite Symposium - Differences in the efficacy of various Chondroitin Sulfate preparations: Facts or fantasy?
Chairperson: ‣ Jean‑Yves Reginster
‣ Welcome and introduction Jean‑Yves Reginster
‣ Efficacy and tolerance of pharmaceutical-grade Chondroitin Sulfate: What does evidence-based medicine say? Jean‑Yves Reginster
‣ Is there a responder profile to pharmaceutical-grade Chondroitin Sulfate? An analysis of the CONCEPT study Olivier Bruyère
‣ CS pharmaceutical grade and CS nutraceuticals how far are they? Chiara Schiraldi
‣ Discussion and conclusion Jean‑Yves Reginster
Saturday, 6 April 2019
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
Meeting Room 101‑102‑103
AGNOVOS BREAKFAST SESSION - ESCEO – AgNovos Young Investigator Award Breakfast Event
‣ Introduction and welcome James Howe
‣ Keynote Andreas Kurth
‣ Award winners speech
12.15 - 13.45
Auditorium A
AMGEN SATELLITE LUNCH SYMPOSIUM - IMPROVING OSTEOPOROSIS CARE - GETTING CLOSER TO THE PATIENT
Chairpersons: ‣ Eugene McCloskey, ‣ Christian Roux
‣ Welcome and introduction Eugene McCloskey, Christian Roux
‣ Estimating the treatment gap in elderly women – a cross-sectional primary care study Socrates Papapoulos
‣ Utility of fracture risk assessment in primary care; identifying the right patient Eugene McCloskey
‣ Managing osteoporosis treatment – challenges and opportunities for primary care physicians Liesbeth Borgermans
‣ Q&A session and meeting close Eugene McCloskey, Christian Roux
12.15 - 13.45
Auditorium B
ELI LILLY SATELLITE LUNCH SYMPOSIUM - 17 Years of Teriparatide: New Insights in the Treatment of Severe Osteoporosis
Chairperson: ‣ Thierry Thomas
‣ Welcome and Introduction Thierry Thomas
‣ New Insights on the Mechanism of Action of Teriparatide Erik Fink Eriksen
‣ New Results of Teriparatide in the Treatment of Severe Osteoporosis Adolfo Diez‑Perez
‣ Question and Answers and Close All
00.01 - 23.59
WCO-IOF-ESCEO
